Julianne Bruno Crispr Therapeutics Ag (CRSP) insider trading activity
Julianne Bruno is Chief Operating Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 6,745 shares of CRSP, which is worth approximately $274,656. The most recent transaction as insider was on Jun 21, 2024, when has been sold 3,366 shares (Common Shares) at a price of $56.09 per share, resulting in proceeds of $188,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
6.75K
0%
3M change
n/a
12M change
Total Value Held
$274,656
Julianne Bruno Transaction History
JB
Julianne Bruno
Chief Operating Officer
Boston, MA